Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

403
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

386
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

A CASE-CONTROL STUDY ON RISK FACTORS OF OSTEOPOROSIS IN PATIENTS WITH CROHN'S DISEASE

Pages

  570-575

Abstract

 Background: OSTEOPOROSIS has been frequently reported in patients with inflammatory bowel diseases, especially CROHN’S DISEASE.Methods: All consecutive CROHN’S DISEASE patients who attended the GI Clinics at Shariati Hospital, Tehran, Iran, from 2004 to 2007 were evaluated. A BMD-DEXA assessment was performed for all patients. Among those patients diagnosed with OSTEOPOROSIS (T score £ -2.5 SD), 30 patients were chosen as study cases. Of those who were not diagnosed with OSTEOPOROSIS, 85 were chosen as the control group. A thorough patient history including: age, sex, body mass index, cumulative corticosteroid dose, previous fracture, history of bowel resection, site and duration of disease, smoking and consumption of calcium and vitamin D, was taken from all patients through a face-toface interview. Independent sample Student’s t-test, Chi-square, and logistic regression analyses were used for data analysis.Results: In this study, a multivariable modeling technique revealed a higher OSTEOPOROSIS risk in those who had a lower body mass index, previous fractures and longer disease duration. A cumulative corticosteroid dose of 10 – 35 g provided the highest OSTEOPOROSIS risk. Age, sex, bowel resection, site of disease, smoking and consumption of calcium and vitamin D did not show any relationship with OSTEOPOROSIS. Conclusion: The highest OSTEOPOROSIS risk was seen in patients with a cumulative 10 – 35 g corticosteroid dose and could be due to both steroid inefficiency in reducing CROHN’S DISEASE inflammation as well as the cumulative drug dose and it’s adverse effect on patients.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    VAHEDI, HOMAYOUN, MOMTAHEN, SH., OLFATI, G., ABTAHI, A., HOSSEINI, SAREH, KAZAZI, A.S.A.D., KHADEMI, HOUMAN, RASHTAK, SH., KHALEGHNEZHAD, R., TABRIZIAN, T., HAMIDI, Z., NOURAEI, MAHDI, MALEKZADEH, FATEMEH, MERAT, SH., NASERI MOGHADAM, S., SOTOUDEHMANESH, R., & ARDESHIR LARIJANI, MOHAMMAD BAGHER. (2009). A CASE-CONTROL STUDY ON RISK FACTORS OF OSTEOPOROSIS IN PATIENTS WITH CROHN'S DISEASE. ARCHIVES OF IRANIAN MEDICINE, 12(6), 570-575. SID. https://sid.ir/paper/280513/en

    Vancouver: Copy

    VAHEDI HOMAYOUN, MOMTAHEN SH., OLFATI G., ABTAHI A., HOSSEINI SAREH, KAZAZI A.S.A.D., KHADEMI HOUMAN, RASHTAK SH., KHALEGHNEZHAD R., TABRIZIAN T., HAMIDI Z., NOURAEI MAHDI, MALEKZADEH FATEMEH, MERAT SH., NASERI MOGHADAM S., SOTOUDEHMANESH R., ARDESHIR LARIJANI MOHAMMAD BAGHER. A CASE-CONTROL STUDY ON RISK FACTORS OF OSTEOPOROSIS IN PATIENTS WITH CROHN'S DISEASE. ARCHIVES OF IRANIAN MEDICINE[Internet]. 2009;12(6):570-575. Available from: https://sid.ir/paper/280513/en

    IEEE: Copy

    HOMAYOUN VAHEDI, SH. MOMTAHEN, G. OLFATI, A. ABTAHI, SAREH HOSSEINI, A.S.A.D. KAZAZI, HOUMAN KHADEMI, SH. RASHTAK, R. KHALEGHNEZHAD, T. TABRIZIAN, Z. HAMIDI, MAHDI NOURAEI, FATEMEH MALEKZADEH, SH. MERAT, S. NASERI MOGHADAM, R. SOTOUDEHMANESH, and MOHAMMAD BAGHER ARDESHIR LARIJANI, “A CASE-CONTROL STUDY ON RISK FACTORS OF OSTEOPOROSIS IN PATIENTS WITH CROHN'S DISEASE,” ARCHIVES OF IRANIAN MEDICINE, vol. 12, no. 6, pp. 570–575, 2009, [Online]. Available: https://sid.ir/paper/280513/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top